Bronchial carcinoid tumor and scintigraphy of somatostatin receptors: Detection of bone metastasis;Tumor carcinoide bronquial y gammagrafía de receptores de somatostatina: Detección de metástasis óseas

Revista Espanola de Medicina Nuclear

Volumn 20, Issue 6, 2001, Pages 431-438

  Banzo, J ^a   Abos M D ^a   Prats, E ^a   Garcia F ^a   Freile, E ^a   Razola, P ^a   Escalera, T ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Bone metastases; Bronchial carcinoid tumor; Somatostatin receptors scintigraphy

Indexed keywords

BISACODYL; FLUOROURACIL; GAMMA INTERFERON; MEDRONATE TECHNETIUM TC 99M; PENTETREOTIDE IN 111; PLANTABEN; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDIUM; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT; SDZ 215 811; SDZ 215-811; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; BONE METASTASIS; BRONCHUS CARCINOID; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FOLLOW UP; HUMAN; LIVER METASTASIS; LUNG SCINTISCANNING; LYMPH NODE METASTASIS; RETROSPECTIVE STUDY; RIB; SARCOIDOSIS; SPLEEN TUMOR; ADULT; AGED; BONE TUMOR; BRONCHUS TUMOR; CARCINOID; CHEMISTRY; COMPARATIVE STUDY; EVALUATION; FEMALE; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; BONE NEOPLASMS; BRONCHIAL NEOPLASMS; CARCINOID TUMOR; FEMALE; HUMANS; INDIUM RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M MEDRONATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TUMOR MARKERS, BIOLOGICAL;

EID: 0035487222     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/s0212-6982(01)71989-1     Document Type: Article

References (39)

1. Modlin IM, Tang LH. Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today). Gastroenterology 1997;112:583-90.
2. Dusmet ME, McKneally MF. Pulmonary and thymic carcinoid tumors. World J Surg 1996;20:189-95.
3. Kulke MH, Mayer RJ. Carcinoid tumors. N Engl J Med 1999;340:858-68.
4. Dávila DG, Dunn WF, Tazelaar HD, Pairolero PC. Bronchial carcinoid tumors. Mayo Clin Proc 1993;68:795-803.
5. McAdams HP, McElaney B, Erasmus J. Chest case of the day. AJR 1995;165:186-91.
6. Limper AH, Carpenter PC, Scheithauer B, Staats BA. The Cushing syndrome induced by bronchial carcinoid tumors. Ann Inter Med 1992;117:209-14.
7. Iser G, Phohl M, Dörr U, Weiss EM, Seif FJ. Ectopic ACTH secretion due to a bronchopulmonary carcinoid localized by somatostatin receptor scintigraphy. Clin Investig 1994;74:887-91.
8. 111In-DTPA octreotide en el diagnóstico de localización. An Med Interna (Madrid) 1999;16:577-9.
9. Doppman JL, Pass HI, Nieman LK, Findling JW, Dwyer AJ, Feuerstein IM, et al. Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs CT. AJR 1991;156:39-43.
10. Forster BB, Müller NL, Miller RR, Nelems B, Evans KG. Neuroendocrine carcinomas of the lung: clinical, radiologic, and pathologic correlation. Radiology 1989;170:441-5.
11. Zwiebel BR, Austin JHM, Grimes MM. Bronchial carcinoid tumors: assessment with CT of location and intratumoral calcification in 31 patients. Radiology 1991;179:483-6.
12. 111 pentetreotide. Thorax 1994;49:284-6.
13. Weiss M, Yellin A, Husza'r M, Eisenstein Z, Bar-Ziv J, Krausz Y. Localization of adrenocorticotropic hormone-secreting bronchial carcinoid tumor by somatosatatin-receptor scintigraphy. Ann Intern Med 1994;121:198-9.
14. 111In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine and non-neuroendocrine tumors of the lung. Preliminary results. J Cardiovasc Surg 1997;38:313-5.
15. 1)-octreótido en el carcinoide bronquial. Rev Esp Med Nuclear, 1998:17:45-8.
16. Musi M, Carbone RG, Bertocchi C, Cantalupi DP, Michetti G, Pugliese C, et al. Bronchial carcinoid tumours: a study of clinicopathological features and role of octreotide scintigraphy. Lung Cancer 1998;22:97-102.
17. De Granda JI, Ramírez JR, Martínez JM, Enrech S, Escobar JA, Herrera de la Rosa A. Derrame pleural con afectación difusa pulmonar y nódulo único subcutáneo como primera manifestación de un tumor carcinoide atípico bronquial. An Med Interna (Madrid) 1997;14:299-301.
18. Barton JC, Hirschowitz BI, Maton PN, Jensen RT. Bone metastases in malignant gastrinoma. Gastroenterology 1986;91:1179-85.
19. Gibril R, Doppman JL, Reynolds JC, Chen CC, Sutliff VE, Yu F, et al. Bone metastases in patients wiht gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in the detection, frequency, location, and effect of their detection on management. J Clin Oncol 1998;16:1040-53.
20. Lebtahi R, Cadiot G, Delahaye N, Genin R, Daou D, Peker MC, et al. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. J Nucl Med 1999;40:1602-8.
21. Ashraf MH. Bronchial carcinoid with osteoblastic metastases. Thorax 1977;32:509-11.
22. Merle-Vincent F, Chevrel G, Lombard-Bohas C, Felmann C, Meunier PJ. Métastases osseuses des tumeurs carcinoïdes bronchiques: a propos de deux observations. Rev Rhum (Ed. Fr.) 1999;66:49-51.
23. Peavy PW, Rogers JV, Clements JL, Burns B. Unusual osteoblastic metastases from carcinoid tumors. Radiology 1973;107:327-330.
24. Pederson RT, Haldak DJ, Ferris RA, MacDonald JS, Schein PS. Osteoblastic bone metastasis in Zolliger-Ellison syndrome. Radiology 1976;118:63-4.
25. Powell JM. Metastatic carcinoid of bone. Report of two cases and review of the literature. Clin Orthop 1988;230:266-72.
26. Manoli RS, Barthelemy CR. Osteolytic and osteoblastic metastases due to carcinoid tumors. Clin Nucl Med 1980;5:102-5.
27. Jolles PR. Rectal carcinoid metastatic to the skeleton. Scintigraphic and radiographic correlation. Clin Nucl Med 1994;19:108-11.
28. Watanabe N, Seto H, Ishiki M, Shimizu M, Kageyama M, Wu YW, et al. I-123 MIBG imaging of metastatic carcinoid tumor from the rectum. Clin Nucl Med 1995;20:357-60.
29. Bomanji J, Mather S, Moyes J, Ellison D, Grossman A, Britton KE, et al. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors. J Nucl Med 1992;33:1121-4.
30. Hoefnagel CA. Metayodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med 1994;21:561-81.
31. Mure A, Lebtabi R, Sarda L, Glikmanas M, Cadiot G, Brochet E, et al. Left ventricular myocardial uptake of a labeled somatostatin analog in carcinoid syndrome. J Nucl Med 1996;37:275-8.
32. 111 octreotide scan in a case of a neuroendocrine tumor of unknown origin. Clin Nucl Med 1999;24:955-8.
33. De Kerviller E, Cadiot G, Lebtahi R, Faraggi M, Le Guludec D, Mignon M. Somatostatin receptor scintigraphy in forty-eight patients with the Zolliger-Ellison syndrome. Eur J Nucl Med. 1994;21:1191-7.
34. Krausz Y, Bar-Ziv J, de Jong RBJ, Ish-Shalom S, Chisin R, Shibley N, et al. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors. Am J Gastroenterol 1998;93:66-70.
35. Frilling A, Malago M, Martin H, Broelsch CE. Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors. Surgery 1998;124:1000-4.
36. Krausz Y, Pfeffer MR, Glase B, Lafair J. Somatostatin-receptor scintigraphy of subcutaneous and thyroid metastases from bronchial carcinoid. J Nucl Med 1996;37:1537-9.
37. Mignon M. Natural history of neuroendocrine enteropancreatic tumors. Digestion 2000;62(Supl 1):51-8
38. Reubi JC, Waser B, Markusse Hm, Krenning EP, Van Hagen M, Laissue JA. Vascular somatostatin receptors in synovium from patients with rhematoid arthritis. Eur J Pharmacol 1994;271:371-8.
39. 111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake. Eur J Nucl Med 1998;25:687-94,